Variant B (VB) of cystatin C has a mutation in its signal peptide (A25T), which interferes with its processing leading to reduced secretion and partial retention in the vicinity of the mitochondria. There are genetic evidences of the association of VB with Alzheimer' disease (AD) and age-related macular degeneration (AMD).
Introduction
Human Cystatin C belongs to the cystatin superfamily of reversible inhibitors of cysteine proteases encompassing the papain and legumain families [1] . The mature cystatin C is a monomeric protein composed of a polypeptide chain of 120 amino acids (13, 343 Da) [2, 3] . The general fold of monomeric inhibitors of the cystatin superfamily has been defined by the crystal structure of chicken cystatin. It is composed of a long helix running across a five-stranded antiparallel β-sheet [3, 4] ( Fig. 1A) . Cystatin C is produced and found in most tissues and body fluids with particular higher concentrations in the cerebrospinal fluid, owing to expression by the choroid plexus. Cystatin C is involved in many biological functions, ranging from bone reabsorption, modulation of inflammatory response, anti-viral and anti-bacterial properties, cell proliferation and growth, tumor metastasis, and to astrocyte differentiation during mouse brain development [5] [6] [7] [8] [9] .
Wild type (WT) cystatin C has been found in amyloid deposits in the brain arteries of elderly people [10, 11] , while the rare mutation L68Q causes Hereditary Cystatin C Amyloid Angiopathy (HCCAA) [12, 13] , a condition in which the patients present fatal cerebral hemorrhage in early adulthood. In vitro, both WT and L68Q cystatins C produce amyloid fibrils [12, 14, 15] . Interestingly, in vitro and in vivo studies have shown that WT cystatin C binds to soluble Aβ protecting this peptide from oligomerization. In addition, cystatin C has been co-localized with Aβ deposits in senile plaques and the vascular cell wall. Altogether, these results suggest that cystatin C might be a neuroprotective protein in Alzheimer's disease (AD) acting as a modulator of amyloidosis [16] [17] [18] .
In the eye, cystatin C is abundantly expressed by the retinal pigment epithelium (RPE) [19] [20] [21] , the monolayer of cells essential for maintaining the homeostasis of the neuroretina and the blood-retina barrier. RPE dysfunction is central to the pathogenesis of age-related macular degeneration (AMD), with various cellular processes contributing to the onset and progression of the disease including: cellular debris accumulation in drusen [22] , changes to the underlying Bruch's membrane (BM) with and without breakage of the blood/retina barrier [23] , impaired clearing of protein aggregates and/or damaged organelles [24, 25] .
The cystatin C variant type B has been associated as a recessive allele with increased risk of AD and exudative AMD [26] [27] [28] [29] [30] . This variant results from a SNP in the cystatin C gene (CST3) signal/leader sequence (1MAGPLRAPLLLLAILAVALAVSPAAG26) (p.Ala25Thr due to a c.G73A
substitution). The 26-amino acid signal sequence of precursor cystatin C is essential for targeting the protein to the ER/Golgi apparatus and processing through the secretory pathway [31, 32] . The A25T substitution decreases the efficiency of cleavage of the signal peptide in the variant B precursor resulting in a protein constituted of 146 amino acids that is abnormally processed in the cell [33] . The variant B precursor cystatin C is processed less efficiently through the secretory pathway resulting in its decreased secretion to the extracellular space, with some of the unprocessed molecules diverted from the secretory pathway accumulating intracellularly in association with the mitochondrial membrane network [33, 34] . The reduced secretion and subsequent decreased concentration of mature cystatin C extracellularly could explain the enhanced AD and AMD risk observed in homozygous patients with variant B.
Here, due to its association to AD and AMD, we investigate the aggregation and amyloid propensity of the variant B, with emphasis on the signal peptide. Using two well validated aggregation predictors, namely AGGRESCAN, which was designed to predict aggregation propensity regions in vivo, and Waltz, which predicts specific amyloid formation regions [35, 36] , we found on the immature form of the protein, four short aggregation-prone sequences, one of them being the leader peptide with very high aggregation/amyloidogenic scores. With these predictions in hands, we carried out in vitro experiments with the leader peptide to corroborate its amyloidogenicity. Our data unequivocally demonstrated that the leader peptide of the variant B cystatin C aggregates instantaneously upon aqueous dilution forming positive Thioflavin-T (Th-T) and Congo-red aggregates. ATR-FTIR, TEM and DLS confirmed the presence of amyloid in solution. The aggregates were shown to be very toxic to neuroblastoma cells cultures. In the light of these results, we propose for the first time a role of the leader peptide on the immature (unprocessed) form of variant B cystatin C in its association with increased risk of AD and AMD. 
Materials and Methods

Prediction of the
Peptides synthesis
The peptides were purchased from CASLO ApS c/o Scion Denmark Technical
Universit. The purity was higher than 98 %. The peptide was weighted and diluted in DMSO to obtain a stock solution of soluble peptide with a concentration of 3 mM.
Peptides Aggregation Assays
Aggregation was performed at different concentrations as stated in legends.
Before each experiment, the stock solution was diluted in PBS pH 7.4 and Th-T was added at 20 µM (Fig. 2B ) or 30 µM ( Fig. 2A) final concentrations. The samples were incubated at 25 o C with no agitation. Samples were excited at 450 nm while emission was collected from 400 to 600 nm on a spectrofluorometer Jasco 8200. Intensity at 482 nm was used to probe amyloid formation.
Congo red (CR) binding assay
The binding of CR to aggregated peptide was evaluated by diluting fivefold the incubated peptide in CR, resulting in a final CR concentration of 10 µM, and recording the absorbance spectra of the mixture in the 380 to 670 nm range in a Cary 400 spectrophotometer (Varian).
Dynamic Light Scattering (DLS) measurements
Peptide solutions were let to aggregate at the conditions stated above (100 µM) and measures were performed at 1 h and after 24 h of aggregation. DLS measurements were performed at 25 °C in a Malvern Zetasizer Nano S90 (Malvern, Worcestershire, UK). Each sample was measured tree times; average distributions are presented.
Infrared spectroscopy
Attenuated total reflectance Fourier transform infrared spectroscopy (ATR FT-IR) was used to determine the secondary structure content of the aggregates formed at different times during the aggregation kinetics. The experiments were carried out using a Bruker Tensor 27 FT-IR spectrometer (Bruker Optics) with a Golden Gate MKII ATR accessory. Each spectrum consists of 16 accumulations measured at a resolution of 2 cm −1 in a wavelength range between 1,700 and 1,600 cm −1 . Infrared spectra were fitted through overlapping Gaussian curves, and the amplitude, mass center, bandwidth at half of the maximum amplitude, and area for each Gaussian function were calculated employing a nonlinear peak-fitting equation using the PeakFit package (Systat Software, San Jose, CA)
Transmission Electron Microscopy (TEM)
Aggregated samples were diluted in Mili-Q water to 10 µM. 5 µl of the solution were absorbed onto carbon-coated copper grids for 5 minutes and blotted to remove excess material. Uranyl acetate (2% w/v) was used for negative staining.
Samples were dried on air for 5 min. Grids were exhaustively scanned with a Hitachi H-7000 transmission electron microscope operating at a voltage of 75 kV.
Neuroblastoma Cell (N2a) Culture and Viability Assay
N2a cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum and 2% antibiotic (gentamicin) in a 5% CO 2 atmosphere for 3 days and then transferred to a 96-well plate and allowed to adhere for 24 h (5,000 cells/well). Following cell adhesion, aggregates were added to achieve final concentration of 5µM. Cells were challenged for 24 h, and final cellular viability was measured by an MTT assay as previously described [37] .
Results and Discussion
Bioinformatics predicts that the signal peptide of variant B cystatin C is aggregation-prone and amyloidogenic
AGGRESCAN is considered a reliable program to predict the aggregation propensity of proteins in vivo [38] since the aggregation score for each amino acid was derived from aggregation assays carried out on a bacterial system [35] .
AGGRESCAN identifies aggregation-prone regions (APR) as stretches of a given sequence at least 5 amino acids long with high aggregation propensity scores [39] .
Recently, the pentapeptide 47 LQVVR 51 from cystatin C was demonstrated to form fibrils in vitro [40] . The same group by using the algorithm AMYLPRED identified two other peptides from the core of cystatin C with high aggregation propensity. These peptides, namely 56 IVAGVNYFLD 65 and 95 AFASFQIYAV 104 (it contains a C97A mutation), were also amyloidogenic upon incubation for several days at pH 5.5. These peptides numerations are from the mature cystatin C. In our Figure 1B , green numeration [41] . Figure 1B) . Therefore, these two APRs almost completely overlap with those previously identified using AMYLPRED [42] .
Interestingly, the signal peptide present in the immature (uncleaved) protein (segment 9-22; LLLLAILAVALAVS) presented even higher aggregation scores than the three previous peptides identified by AGGRESCAN. The primary sequence of precursor cystatin C, including the signal peptide, is presented in Figure 1B and the aggregation prone regions are highlighted.
APRs within the primary sequence of proteins are flanked by gatekeeper residues such as proline and charged amino acids, which modulate aggregation by opposing nucleation of aggregates [43, 44] . In the case of the four stretches of cystatin C identified by AGGRESCAN, we could observe the presence of these gatekeeper residues. In particular, in the case of the signal peptide, the sequence is flanked by two proline residues at positions 8 and 23 (P-9LLLLAILAVALAVS22-P). Recently, our group identified the gatekeeper residues in the amyloidogenic protein transthyretin. By replacing one of these residues in the sequence of a peptide derived from TTR by a hydrophobic amino acid (K35L), we could convert a non-aggregating peptide into a highly aggregation-prone one [45] .
Next, in order to investigate whether these APRs would also exhibit high scores for forming amyloid-specific aggregates, the Waltz program was utilized ( We also used other algorithms such as TANGO [46] , Zipper DB [47] and AMYLPRED2 to analyze the aggregation and amyloid propensity of the cystatin C signal peptide. TANGO and AMYLPRED2 predicted the 9-20 and 9-21 stretches to be aggregation-prone, respectively, whereas Zipper DB predicted the sequence 9-17 to be highly amyloidogenic. Because the methods we employed here for computational predictions rely on very different principles, the prediction of the signal peptide being highly aggregation prone and amyloidogenic was considered to be very robust. The intrinsic high hydrophobicity of signal peptides does not always implies that they can form typical beta sheet rich ordered amyloid fibrils, as cystatin C 
Variant B Cystatin C signal peptide is able to form amyloid fibrils in vitro
Having in silico evidence that the signal peptide presents high aggregation propensity and amyloidogenicity, we synthetized the peptide with the mutation A25T (1MAGPLRAPLLLLAILAVALAVSPATG26) (Fig. 1B) and incubated it at increasing concentrations (5 µM to 100 µM) for 1 h at pH 7.4, 25 o C under stagnant conditions. As shown in Figure 2A , there was a proportional increase in Thioflavin-T (Th-T) emission at increasing concentrations of the peptide, suggesting formation of amyloid-like aggregates in solution. Congo red (CR) binding assays were also performed to confirm the presence of amyloid-like aggregates ( Fig. 2A, inset) .
In order to follow the aggregation kinetics of the signal peptide, increasing concentrations of the peptide were incubated with Th-T and its fluorescence emission was collected over time (Fig. 2B) . Notably, even at very low peptide concentration such as 5 µM, maximum emission of Th-T was attained in the first acquisition points, with no further change in the fluorescence signal of the probe even after 3 days under aggregation conditions. This suggests that aggregation of the signal peptide of cystatin C is very fast. We tried several conditions to slow down the aggregation process of the signal peptide such as low temperature (4 and 8 o C) and addition of 5, 10 and 15% DMSO to the aggregating buffer without any success (not shown).
In order to confirm the instantaneous aggregation of the signal peptide, a suspension with 50 µM peptide diluted into 30 µM Th-T was filtered through a 0.22 micrometer filter before measurements. The filter became yellow due to the retention of the aggregates bound to Th-T. The filtered solution, when let to aggregate, was not able to bind additional Th-T since all soluble peptide was converted into amyloid aggregates that were retained in the filter (Fig. 2B, dashed line) .
Characterizing the morphology, secondary structure and toxicity of the aggregates formed by the signal peptide of variant B cystatin C Next, we used TEM to study the morphology of the species present at different times of aggregation (Fig. 3A) . Interestingly, although Th-T binding has already leveled-off at 1 h under aggregation conditions, the great majority of the aggregated material presented an amorphous appearance and only few amyloid fibrils were observed at this time (Fig. 3A, left) . The binding of Th-T to these amorphous species suggests that they already present cross-β fold able to accommodate this probe. These species are on-pathway to fibril formation since after 72 h under aggregation condition only mature fibrils were observed by TEM (Fig. 3A, right) . At 24 h, it was already possible to see the presence of fibrils but small amorphous aggregates still remained (Fig. 3A, middle) .
In order to get insights into the secondary structural changes that take place with the signal peptide upon aggregation, we took advantage of ATR-FTIR (Fig. 3   B) . Left panel shows the FTIR spectra of the peptide dried from a stock solution with 100% DMSO (continuous line) and those collected during the first hour of aggregation. As seen, in DMSO the peptide presented a unique and broad peak centered at 1,660 cm -1 , which corresponds to disordered, random coiled structures, which is a strong evidence that the peptide is monomeric in DMSO [48] [49] [50] .
In the initial times of aggregation (up to 1 h), the spectra changed and a new peak at 1,628 cm -1 appeared, which was assigned to β-sheet structures. At the same time, the peak related to random-coil structures (1,660 cm -1 ) decreased but was still present. The presence of β-sheet structures in these initial aggregates explains why these species bind Th-T (as shown in Fig. 2 ), but they are not fully organized, as seen by TEM (Fig. 3A, left) .
As aggregation proceeded for longer times (16, 24 and 72 h), the peak of β-sheet (1,627 cm -1 ) increased even further, with a concomitant decrease of the peak of random coil at 1,660 cm -1 . Table 1 summarizes the secondary structural changes that take place upon aggregation of the signal peptide of cystatin C.
Next, to further confirm the difference in sizes of the species formed at 1 and 24 h, DLS measurements were performed (Fig. 3C) . The main sizes of the two more prevalent species present at 1 h were 0.194 nm +0.06 nm and 904 +32.14 nm. After 24 h under aggregation conditions, there were two species present, one with 947 +134
nm and an extreme large species with 3,008 +500 nm. Interestingly and corroborating the FTIR data, the species with around 900 nm were still present at 24 h. Given the fact that the aggregation pathways of aggregation-prone proteins are distinct leading to the accumulation of a myriad of aggregated species with different size and morphologies, it is difficult to make a direct comparison of the species sizes observed here with others. However, initial fibrillar species from Aβ peptide have been shown to have sizes from 200 to 700 nm [51, 52] . In another study [53] , the formation of transthyretin fibrillar oligomers of 1,000 nm and mature fibrils with mean size of 4,000 nm was reported [54] , in accordance with our DLS data where early aggregating species with 900 nm and mature fibrils with 3,000 nm were detected. We performed a calibration assay using a standard solution of silicone particles and the expected size was found (342 nm).
Next, neuroblastoma cell line N2a was used to probe the cytotoxicity of the aggregates formed at 1 and 24 h and cell viability was evaluated by MTT assays. Both aggregates tested at 5 µM concentration were very cytotoxic, killing ~40 % of the cells (Fig. 3D) .
Conclusions
The substitution A25T in the signal peptide of the variant B precursor cystatin C compromises its cleavage and/or processing precluding the efficient formation of the mature form of the protein, which is secreted from the cells to the extracellular milieu where it exerts its biochemical effect as a cysteine protease inhibitor. We have modeled the potential impact of the Ala to Thr mutation with AGGRESCAN, Tango and Waltz. Neither Tango nor Waltz detected any change in the extension of the aggregation-prone regions or in the overall predicted aggregation/amyloid propensity.
AGGRESCAN did not identify any change in the extension of the aggregation-prone regions and the increase in overall aggregation propensity was only of 0.7%. A model of the functional consequences for trafficking and protein aggregation of this variant precursor cystatin C is presented in Figure 4 . As previously shown, in the extracellular space mature cystatin C interacts with Aβ diminishing its aggregation [17, 18] . An inefficiently cleaved/processed variant B cystatin C leads on one hand to a significantly reduced secretion of the mature cystatin C as shown previously [33, 34] and, on the other, to the accumulation of full length variant precursor protein containing the mutated, highly amyloidogenic leader. On the contrary, the WT signal peptide is excised from the normal cystatin c protein during its processing and should be completely cleaved. To our knowledge, there is no description of the accumulation/aggregation of the WT signal peptide inside RPE cells. In the light of our data, it is tempting to suggest that this variant might aggregate into amyloid fibrils increased proteolytic action at its extracellular sites of activity. Also, there will be less available protein to interact with Aβ peptide, thus enhancing its aggregation, which may explain the variant B cystatin C association with a higher risk of developing AD.
As the amyloid deposits are the histological hallmark of AD, drusen are the extracellular deposits found in AMD. The presence of Aβ peptide has been reported in patients with severe forms of AMD [55] [56] [57] [58] . The involvement of protein aggregation in AMD pathogenesis is suggested by the presence of various toxic amyloid structures in drusen [56, 59] and, indirectly, by the decrease of the AMD risk obtained through anti-amyloid treatment in a mouse model [60] . Variant B cystatin C aggregation may therefore contribute to AMD pathogenesis. In addition, if this mutation avoids the observed partnership between cystatin C and Aβ peptide it can account for the higher incidence of AD in homozygous patients. Further work is being carried out to investigate amyloid deposits formed by this variant inside RPE cells.
More experimental approaches are necessary to reveal in full the mechanism of action of variant B cystatin C in these major neurodegenerative diseases and we are actively pursuing such studies. With the actual lack of any in vitro aggregation experimental evidence to link the higher incidence of AD and AMD with variant B, we believe that the present study provides the important first clues for further investigations.
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